Cargando…
Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the elderly, resulting in gradual destruction of cognitive abilities. Research on the development of various AD treatments is underway; however, no definitive treatment has been developed yet. Herein, we present in...
Autores principales: | Mo, Hyunkyung, Kim, Juryun, Kim, Jennifer Yejean, Kim, Jang Woon, Han, Heeju, Choi, Si Hwa, Rim, Yeri Alice, Ju, Ji Hyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634159/ https://www.ncbi.nlm.nih.gov/pubmed/37946307 http://dx.doi.org/10.1186/s40035-023-00384-8 |
Ejemplares similares
-
Mitigating Effect of Estrogen in Alzheimer’s Disease-Mimicking Cerebral Organoid
por: Kim, Jennifer Yejean, et al.
Publicado: (2022) -
Review of the Current Trends in Clinical Trials Involving Induced Pluripotent Stem Cells
por: Kim, Jennifer Yejean, et al.
Publicado: (2021) -
Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis
por: Kim, Juryun, et al.
Publicado: (2018) -
Recent updates of stem cell-based erythropoiesis
por: Han, Heeju, et al.
Publicado: (2023) -
Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis
por: Lee, Jaecheol, et al.
Publicado: (2014)